What is the dosage of Cometriq?

Cometriq is available in 4 dosages, including 20 mg Cap, mixed Pack, mixed Pack and mixed Pack

What does Cometriq treat?

Cometriq treats Renal Cell Carcinoma

What is Cometriq made of?

Cometriq contains cabozantinib which is a Kinase Inhibitor

How is Cometriq administered?

Cometriq is administered as a Oral Pill or Pack

What is Cometriq mechanism of action?

Cometriq mechanism of action is Protein Kinase Inhibitors

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Cometriq

(cabozantinib)

cabozantinib 20 MG Oral Capsule [Cometriq]cabozantinib 80 MG Oral Capsule [Cometriq]

NO BLACK BOX WARNING

Dosage & administration

* Recommended Dose: 140 mg orally, once daily.
* Instruct patients not to eat for at least 2 hours before and at least 1 hour after taking COMETRIQ.
* Do NOT substitute COMETRIQ capsules with cabozantinib tablets.
* Hepatic Impairment: The recommended starting dose of COMETRIQ is 80 mg in patients with mild or moderate hepatic impairment.

drug label

Cometriq prescribing information

Have more Cometriq questions?

Submit MSL Request

Learn More

Need to report a Cometriq issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Cometriq samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Cometriq Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

EASE Enrollment Form (Form 1/2 - Physician Form)

EASE Enrollment Patient Authorization (Form 2/2)

EASE Enrollment Patient Authorization (Form 2/2) - Online

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Cometriq Financial assistance options

Co-pay savings program

commercial only

EASE Enrollment Form (Form 1/2 - Physician Form)

EASE Enrollment Patient Authorization (Form 2/2)

EASE Enrollment Patient Authorization (Form 2/2) - Online

Enroll in Patient Savings Program

Enroll in Patient Savings Program - HCP Office

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

EASE Enrollment Form (Form 1/2 - Physician Form)

EASE Enrollment Patient Authorization (Form 2/2)

EASE Enrollment Patient Authorization (Form 2/2) - Online

Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Cometriq Patient education